Theravia
About Theravia
Theravia is a Healthcare company, and was acquired by Norgine in April 2025. Therapies for rare and neglected diseases are developed and promoted. Its focus areas include Traditional Pharmaceuticals, Traditional Nutraceuticals and Diversified. Its legal entity is Theravia Inc.
Company details
Specialized pharmaceuticals, medical devices, and diagnostics are developed by Theravia for rare and debilitating conditions. Registration and promotion of these products are handled within the biotechnology sector, with operations centered on high-value medical solutions. Effective partnerships are formed to innovate and advance therapeutic options. Focus is placed on safe and effective treatments for underserved diseases, without specified geographic operations.
- Stage Acquired
- SectorsHealthcare
- Website theravia.com
- Social LinkedIn
- Acquired by Norgine (Apr 2025)
- Legal Name Theravia Inc
Investors in Theravia
Theravia has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Norgine.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Proprietary therapeutic products for gastrointestinal diseases are developed and marketed. | 1906 | norgine.com | Amsterdam, Netherlands |
Investor details for Theravia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Web traffic of Theravia
The website of Theravia (theravia.com) receives about 2.7K visits a month.
- Monthly visits2.7K
▲ 147.2% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Theravia
Specialized pharmaceuticals, medical devices, and diagnostics are developed by Theravia for rare and debilitating conditions. Registration and promotion of these products are handled within the biotechnology sector, with operations centered on high-value medical solutions. Effective partnerships are formed to innovate and advance therapeutic options. Focus is placed on safe and effective treatments for underserved diseases, without specified geographic operations.
Theravia has 1 investor. Key investors include Norgine.
Theravia operates through Theravia Inc.
Yes. Theravia was acquired by Norgine in April 2025.